LENZ THERAPEUTICS, INC. Revenue from Contract with Customer, Including Assessed Tax
LENZ THERAPEUTICS, INC. (LENZ) reported Revenue from Contract with Customer, Including Assessed Tax of $12.50 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2025-11-05
- LENZ THERAPEUTICS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $12.50M.
- LENZ THERAPEUTICS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $5.00M.
- LENZ THERAPEUTICS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2024-09-30 was $0.00.
- LENZ THERAPEUTICS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2024-06-30 was $0.00.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month |
|---|---|---|---|
| 2025-09-30 | $12.50M 10-Q · filed 2025-11-05 | $17.50M derived: sum of 2 quarters · filed 2025-11-05 | $17.50M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $5.00M 10-Q · filed 2025-07-30 | $5.00M 10-Q · filed 2025-07-30 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 10-Q · filed 2025-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |